Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Jul;109(3):679–684. doi: 10.1111/j.1476-5381.1993.tb13627.x

Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats.

K Harada 1, A Miwa 1, S Kaneta 1, T Izawa 1, H Fukushima 1, N Ogawa 1
PMCID: PMC2175614  PMID: 7689399

Abstract

1. The effect of KRN2391, a novel vasodilator, on the changes of electrocardiogram caused by endothelin-1 (ET-1) was studied in anaesthetized rats and compared with the effects of nicorandil and diltiazem. In addition, the effect of KRN2391 on the action potential of guinea-pig papillary muscle was studied. 2. The intracoronary administration (i.c.) of ET-1 (5 micrograms) induced not only ST segment elevation of the electrocardiogram due to contraction of the coronary artery, but also arrhythmias involving atrioventricular block (A-V block), ventricular premature contraction (VPC) and ventricular fibrillation (VF), and resulted in death in most animals. However, the administration of methacholine (3 micrograms, i.c.) produced ST segment elevation alone without developing arrhythmias. 3. Pretreatment with intravenous administration of KRN2391 (30 micrograms kg-1) inhibited the ST segment elevation and the development of arrhythmias induced by ET-1, and decreased the incidence of death. 4. Nicorandil (1000 micrograms kg-1) prevented the ST segment elevation without suppression of the occurrence of VF. Diltiazem (100 micrograms kg-1) suppressed both the ST segment elevation and the occurrence of VF but not other arrhythmias. Nicorandil at 3000 micrograms kg-1 and diltiazem at 300 micrograms kg-1 produced not only a suppression of ST segment elevation and VF incidence but also a decrease in the occurrence of arrhythmias. These doses of nicorandil and diltiazem produced a decrease in death in a dose-dependent manner. 5. KRN2391 (10 and 30 micrograms kg-1), nicorandil (1000 and 3000 micrograms kg-1) and diltiazem (100 and 300 micrograms kg-1) significantly decreased mean blood pressure in a dose-dependent manner.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
679

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aono J., Akima M., Sakai K. Effects of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) on methacholine-induced ECG changes in intact anesthetized rats. Jpn J Pharmacol. 1981 Oct;31(5):823–830. doi: 10.1254/jjp.31.823. [DOI] [PubMed] [Google Scholar]
  2. Billman G. E. The antiarrhythmic and antifibrillatory effects of calcium antagonists. J Cardiovasc Pharmacol. 1991;18 (Suppl 10):S107–S117. [PubMed] [Google Scholar]
  3. Cook N. S., Weir S. W., Danzeisen M. C. Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine. Br J Pharmacol. 1988 Nov;95(3):741–752. doi: 10.1111/j.1476-5381.1988.tb11700.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kashiwabara T., Nakajima S., Izawa T., Fukushima H., Nishikori K. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta. Eur J Pharmacol. 1991 Apr 10;196(1):1–7. doi: 10.1016/0014-2999(91)90401-b. [DOI] [PubMed] [Google Scholar]
  5. Kim S., Morimoto S., Koh E., Miyashita Y., Ogihara T. Comparison of effects of a potassium channel opener BRL34915, a specific potassium ionophore valinomycin and calcium channel blockers on endothelin-induced vascular contraction. Biochem Biophys Res Commun. 1989 Nov 15;164(3):1003–1008. doi: 10.1016/0006-291x(89)91769-5. [DOI] [PubMed] [Google Scholar]
  6. Kojima M., Ban T. Nicorandil shortens action potential duration and antagonises the reduction of Vmax by lidocaine but not by disopyramide in guinea-pig papillary muscles. Naunyn Schmiedebergs Arch Pharmacol. 1988 Feb;337(2):203–212. doi: 10.1007/BF00169249. [DOI] [PubMed] [Google Scholar]
  7. Martin C. L., Chinn K. Pinacidil opens ATP-dependent K+ channels in cardiac myocytes in an ATP- and temperature-dependent manner. J Cardiovasc Pharmacol. 1990 Mar;15(3):510–514. doi: 10.1097/00005344-199003000-00024. [DOI] [PubMed] [Google Scholar]
  8. Miyoshi Y., Nakaya Y., Wakatsuki T., Nakaya S., Fujino K., Saito K., Inoue I. Endothelin blocks ATP-sensitive K+ channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res. 1992 Mar;70(3):612–616. doi: 10.1161/01.res.70.3.612. [DOI] [PubMed] [Google Scholar]
  9. Neubauer S., Ertl G., Haas U., Pulzer F., Kochsiek K. Effects of endothelin-1 in isolated perfused rat heart. J Cardiovasc Pharmacol. 1990 Jul;16(1):1–8. doi: 10.1097/00005344-199007000-00001. [DOI] [PubMed] [Google Scholar]
  10. Nichols A. J., Koster P. F., Ohlstein E. H. The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog. Br J Pharmacol. 1990 Mar;99(3):597–601. doi: 10.1111/j.1476-5381.1990.tb12975.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Osterrieder W. Modification of K+ conductance of heart cell membrane by BRL 34915. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jan;337(1):93–97. doi: 10.1007/BF00169483. [DOI] [PubMed] [Google Scholar]
  12. Sakai K., Akima M., Aono J. Evaluation of drug effects in a new experimental model of angina pectoris in the intact anesthetized rat. J Pharmacol Methods. 1981 Jun;5(4):325–336. doi: 10.1016/0160-5402(81)90045-0. [DOI] [PubMed] [Google Scholar]
  13. Taira N. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview. J Cardiovasc Pharmacol. 1987;10 (Suppl 8):S1–S9. [PubMed] [Google Scholar]
  14. Toyo-oka T., Aizawa T., Suzuki N., Hirata Y., Miyauchi T., Shin W. S., Yanagisawa M., Masaki T., Sugimoto T. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation. 1991 Feb;83(2):476–483. doi: 10.1161/01.cir.83.2.476. [DOI] [PubMed] [Google Scholar]
  15. Turner N. C., Dollery C. T., Williams A. J. Endothelin-1-induced contractions of vascular and tracheal smooth muscle: effects of nicardipine and BRL 34915. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S180–S182. doi: 10.1097/00005344-198900135-00049. [DOI] [PubMed] [Google Scholar]
  16. Van Renterghem C., Vigne P., Barhanin J., Schmid-Alliana A., Frelin C., Lazdunski M. Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem Biophys Res Commun. 1988 Dec 30;157(3):977–985. doi: 10.1016/s0006-291x(88)80970-7. [DOI] [PubMed] [Google Scholar]
  17. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  18. Yorikane R., Koike H., Miyake S. Electrophysiological effects of endothelin-1 on canine myocardial cells. J Cardiovasc Pharmacol. 1991;17 (Suppl 7):S159–S162. doi: 10.1097/00005344-199100177-00044. [DOI] [PubMed] [Google Scholar]
  19. Yorikane R., Koike H. The arrhythmogenic action of endothelin in rats. Jpn J Pharmacol. 1990 Jun;53(2):259–263. doi: 10.1254/jjp.53.259. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES